Algenis
21 September 2018
Algenis specializes in the production, formulation, and clinical development of bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases.
You may be interested in...
-
2024 LAVCA Top & Emerging Women Investors; Big Bets Raises ~USD24.5m for Brazil VC Fund
-
VEF Exits Brazil’s Gringo To Sem Parar
VEF fully exited Brazil-based vehicle monitoring platform Gringo, via a sale to Sem Parar...
-
Treecorp Invests in Brazil’s Decolores
Treecorp invested in Decolores, a Brazil-based producer of marble, granite, quartzite and...
-
Just Launched: LAVCA 2024 Top & Emerging Women Investors in Latin America